These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 23777987

  • 1. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH, Kwon MJ, Choi EJ, Zheng YF, Yoon KD, Liu KH, Bae SK.
    Chem Biol Interact; 2013 Sep 05; 205(1):11-9. PubMed ID: 23777987
    [Abstract] [Full Text] [Related]

  • 2. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
    Jacobson PA, Green K, Birnbaum A, Remmel RP.
    Cancer Chemother Pharmacol; 2002 Jun 05; 49(6):461-7. PubMed ID: 12107550
    [Abstract] [Full Text] [Related]

  • 3. Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes.
    Bae SK, Cao S, Seo KA, Kim H, Kim MJ, Shon JH, Liu KH, Zhou HH, Shin JG.
    Drug Metab Dispos; 2008 Aug 05; 36(8):1679-88. PubMed ID: 18474675
    [Abstract] [Full Text] [Related]

  • 4. Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism.
    Rae JM, Soukhova NV, Flockhart DA, Desta Z.
    Drug Metab Dispos; 2002 May 05; 30(5):525-30. PubMed ID: 11950782
    [Abstract] [Full Text] [Related]

  • 5. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
    Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O.
    Drug Metab Dispos; 2004 Jun 05; 32(6):626-31. PubMed ID: 15155554
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of cytochrome P450 2D6 by Sarpogrelate and its active metabolite, M-1, in human liver microsomes.
    Cho DY, Bae SH, Lee JK, Kim YW, Kim BT, Bae SK.
    Drug Metab Dispos; 2014 Jan 05; 42(1):33-9. PubMed ID: 24167220
    [Abstract] [Full Text] [Related]

  • 7. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
    Misaka S, Kawabe K, Onoue S, Werba JP, Giroli M, Tamaki S, Kan T, Kimura J, Watanabe H, Yamada S.
    Drug Metab Pharmacokinet; 2013 Jan 05; 28(3):244-9. PubMed ID: 23268924
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.
    Kiang TK, Ho PC, Anari MR, Tong V, Abbott FS, Chang TK.
    Toxicol Sci; 2006 Dec 05; 94(2):261-71. PubMed ID: 16945988
    [Abstract] [Full Text] [Related]

  • 10. Validation of (-)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomes.
    Cai X, Wang RW, Edom RW, Evans DC, Shou M, Rodrigues AD, Liu W, Dean DC, Baillie TA.
    Drug Metab Dispos; 2004 Jun 05; 32(6):584-6. PubMed ID: 15155548
    [Abstract] [Full Text] [Related]

  • 11. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X, Wang JS, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2002 Jan 05; 57(11):799-804. PubMed ID: 11868802
    [Abstract] [Full Text] [Related]

  • 12. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
    Chang Y, Fang WB, Lin SN, Moody DE.
    Basic Clin Pharmacol Toxicol; 2011 Jan 05; 108(1):55-62. PubMed ID: 20825389
    [Abstract] [Full Text] [Related]

  • 13. Stereoselective metabolism of endosulfan by human liver microsomes and human cytochrome P450 isoforms.
    Lee HK, Moon JK, Chang CH, Choi H, Park HW, Park BS, Lee HS, Hwang EC, Lee YD, Liu KH, Kim JH.
    Drug Metab Dispos; 2006 Jul 05; 34(7):1090-5. PubMed ID: 16581944
    [Abstract] [Full Text] [Related]

  • 14. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.
    Court MH, Duan SX, Hesse LM, Venkatakrishnan K, Greenblatt DJ.
    Anesthesiology; 2001 Jan 05; 94(1):110-9. PubMed ID: 11135730
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine.
    Richter T, Mürdter TE, Heinkele G, Pleiss J, Tatzel S, Schwab M, Eichelbaum M, Zanger UM.
    J Pharmacol Exp Ther; 2004 Jan 05; 308(1):189-97. PubMed ID: 14563790
    [Abstract] [Full Text] [Related]

  • 18. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
    Bhateria M, Ramakrishna R, Puttrevu SK, Saxena AK, Bhatta RS.
    Chem Biol Interact; 2016 Aug 25; 256():257-65. PubMed ID: 27387538
    [Abstract] [Full Text] [Related]

  • 19. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X, Wang JS, Kivistö KT, Neuvonen PJ, Backman JT.
    Br J Clin Pharmacol; 2001 Nov 25; 52(5):547-53. PubMed ID: 11736863
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Micuda S, Mundlova L, Anzenbacherova E, Anzenbacher P, Chladek J, Fuksa L, Martinkova J.
    Eur J Clin Pharmacol; 2004 Oct 25; 60(8):583-9. PubMed ID: 15378224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.